The New York Obesity Nutrition Research Center


Peer Reviewed

(Jan 2006 – Dec 2006)

1.   Augustus AS, Buchanan J, Park T-S, Hirata K, Noh H, Sun J, Homma S, D'armiento J, Abel ED, Goldberg IJ. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction, J Biol Chem, 281:8716-8723, 2006. PMID: 16410253. (Core: HM)

2.   Berk ES, Kovera AJ, Boozer CN, Pi-Sunyer FX, Albu JB. Metabolic inflexibility in substrate use is present in African-American but not Caucasian healthy, premenopausal, nondiabetic women. J Clin Endocrinol Metab. 2006;91(10):4099-106. PMCID: PMC2670464 (Core: BC, HM and CL)

3.   Brownley, K.A., Light, K.C., Grewen, K.M., Hinderliter, A.L., & West, S.G. Dietary sodium restriction alters postprandial ghrelin: Implications for race differences in obesity. Ethnicity & Disease, 2006 16(4), 844-851. PMID: 17061736. (Core: HM)

4.   Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN, Jr. Serum iron and body fat distribution in a multiethnic cohort of adults living in New York City. J Am Diet Assoc 2006; 106(5):680-684. (Core: BC, BS, and HM)

5.   Chung WK, Leibel RL. The links between obesity, leptin, and prostate cancer. Cancer J 2006; 12(3):178-181. (Core: MGMB, HM)

6.   Codner, E., Deng, L., Pérez-Bravo, F., Román, R., Lanzano, P., Cassorla, F.,and  Chung, W.K., Glucokinase mutations in young children with hyperglycemia.  Diabetes and Metabolism Research and Reviews. 2006. 22(5):348-55. (Core: MGMB, HM)

7.   Dubois S, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E and the Look AHEAD Adipose Research Group* . Adipose tissue expression of genes involved in adipocyte differentiation is decreased in obese subjects with type 2 diabetes. Obesity Research, 2006. 14:1543-1552. (Core: HM)

8.   Engelson ES, Agin D, Kenya S, Werber-Zion G, Luty B, Albu JB, Kotler DP. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Metabolism. 2006;55(10):1327-36. PMID: 16979403 (Core: BC, CL and HM)

9.   Fernandez JR, Willig A, Jones A, Shriver MD, Albu J, Allison DB. Genetic admixture is associated with visceral adipose tissue in Puerto Rican women. Int J Body Comp 2006. 4(3): 137-143. (Core: HM and  BC)

10. Gallagher D, Albu J, He Q, Heshka S, Boxt L, Krasnow N, Elia M. Small organs with a high metabolic rate explain lower resting energy expenditure in African American than in white adults. Am J Clin Nutr. 2006;83(5):1062-7. PMCID: PMC1847651 (Core: BC, BS, CL, and HM)

11. Gluck M, Kwon A, Phair D, Jaffe J, Hashim S, Geliebter A. Ghrelin Levels are Higher Following a Cold Stress Compared to a Control Condition and are Greater in Obese Women with Binge Eating Disorder (BED) compared to Non-BED. Obes. Res 2006, 14(9), A206. (Core: HM)

12.  Goldman, N. A., Katz EB, Glenn AS, Weldon RH, Fezzari M, Jones JG, Runowicz CD, Goldberg GL, and Charron MJ.  Expression of GLUT8, a novel glucose transport facilitator, in normal endometrium and endometrial adenocarcinoma.  Modern Pathology 2006; 19:1429-1436. (Core: HM)

13. Greenberg JA, Geliebter A, Boozer CN. Coffee, diabetes, and weight control. Am. J. Clin. Nutr 2006;84: 682-693. (Core: HM)

14.        Kishore PTonelli JKoppaka SFratila CBose ALee DEReddy KHawkins M. Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes. Diabetes 2006; 55(6):1761-1768. (Core: MGMB and HM)

15. Kitamura T, Feng Y, Kitamura YI, Chua SC, Jr., Xu AW, Barsh GS, Rossetti L, Accili D. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med. 2006;12(5):534-40. (Core: MGMB, IB, AEP, AT and HM)

16. Kitamura T, Ido-Kitamura Y, Funahashi Y, Shawber CL, Castrillon DH, Kollipara R, DePinho RA, Kitajewski J and Accili D. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. 2007 J. Clin. Invest. 117: 2477-2485. PMC1950461. (HM)

17. Korner J, Inabnet W, Conwell IM, Taveras C, Daud A, Olivero-Rivera L, Restuccia NL, Bessler M. Differential effects of gastric bypass and banding on plasma PYY, ghrelin and insulin levels. Obesity. 2006; 14:1553-61. (Core: HM)

18. Laferrère B, Abraham C, Awad M, Jean-Baptiste S, Hart A.B,  Garcia-Lorda P, Kokkoris P, Russell DC. Inhibiting Endogenous Cortisol  Blunts the Meal-Entrained Rise in Serum Leptin. J Clin Endo, Metab  91(6):2232-8, 2006. PMCID: PMC2825044. (Core: BS, HM and IB)

19. Laferrère B, Hart AB, Bowers C.Y. Obese subjects respond to the  stimulatory effect of the ghrelin agonist Growth Hormone Releasing  Peptide -2 (GHRP-2) on food intake. Obesity 14(6):1056-1063, 2006. PMCID: PMC2824649. (Core: BS, HM and IB)

20. Noh H-L, Okajima K, Molkentin JD, Homma S, Goldberg IJ. Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction. AJ Physio, Endo/Metab. 291:E755-60, 2006. PMID: 16684851. (HM)

21. Phan LK, Chung WK, Leibel RL. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity. Am J Physiol Endocrinol Metab 2006; 291(3):E611-E620. (Core: MGMB, HM and AT)

22. Qi Y, Nie Z, Lee YS, Singhal NS, Scherer PE, Lazar MA, Ahima RS. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 2006; 55(11):3083-3090. (Core: MGMB and HM)

23. Shen W, Punyanitya M, Chen J, Gallagher D, Albu J, Pi-Sunyer X, Lewis CE, Grunfeld C, Heshka S, Heymsfield SB. Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (Silver Spring). 2006;14(4):727-36. PMCID: PMC1894647 (Core: BC, BS and HM)

24. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116(1):115-124. (Core: IB, AEP, MGMB and HM)

25. Yamaguchi, J., Conlon, D.M., Liang, J.J., Ginsberg, H.N.  Translocation Efficiency of Apolipoprotein B Is Determined by the Presence of b-Sheet Domains.  J Biol Chem 281:27063-71, 2006. (Core: HM)

26. Zhang, YL., Hernandez-Ono, A., Siri, P., Weisberg, S., Conlon, D., Graham, MJ., Crooke, RM.,Huang, L-S., Ginsberg, HN.  Aberrant Hepatic Expression of PPARg2 Stimulates Hepatic Lipogenesis in a Mouse Model of Obesity, Insulin Resistance, Dyslipidemia, and Hepatic Steatosis.  J Biol Chem 8; 28:37603-15, 2006. (Core: HM)

(Jan 2007 – Dec, 2007)

27. Albu JB, Kenya S, He Q, Wainwright M, Berk E, Heshka S, Kotler DP, Engelson ES. Independent associations of insulin resistance with higher whole-body intermuscular and relatively less leg subcutaneous adipose tissue in HIV-infected obese women. Am J Clin Nutr, 86(1): 100-106, 2007; (Core: BC, HM, CL and BS)

28. Adachi M, Osawa Y, Uchinami H , Kitamura T, Accili D, Brenner DA. The Forkhead Transcription Factor FoxO1 Regulates Proliferation and Transdifferentiation of Hepatic Stellate Cells. Gastroenterology 2007. 132:1434-1446. PMID: 17408630. (Core: HM and MGMB)

29. Azuma K, Heilbronn LK, Albu JB, Smith SR, Ravussin E, Kelley DE; and the Look AHEAD Adipose Research Group. Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2007 Jul; 293(1):E435-42. Epub 2007 Apr 17. (Core: HM and CL)

30. Buteau J, Shlien A, Foisy S, Accili D. Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem. 2007;282(1):287-93. (Core: AT, MGMB and HM)

31. Conarello, S.L., Jiang G, Mu J, Li Z, Woods J, Zycband E, Ronan J, Liu F, Roy RS, Zhu L, Charron MJ and Zhang BB.  Glucagon receptor knockout mice are resistant to diet induced obesity and streptozotocin-mediated β-cell loss and hyperglycemia.  Diabetologia 2007 50:142-50. (Core: HM)

32. Falutz J, Allas S, Blot K, Potvin D, Kotler D, Somero M Berger D, Brown S, Richmond G, Fessel J, Grinspoon S, Effects of a Growth Hormone Releasing Factor Analogue (Growth Hormone Releasing Hormone) on Body Composition and Metabolic Indices in HIV- infected patients.  N Engl J Med.  2007;357:2359-70.(Core: HM)

33. Florescu D, Kotler DP. Insulin resistance, glucose intolerance, and diabetes mellitus in HIV-infected patients.  Antiviral Therapy 2007;12:149-62. PMID: 17503657. (Core: HM)

34. Freda PU, Chung WK, Matsuoka N, Walsh N, Walsh JE, Kanibir MN, Kleinman G, Wang Y, Bruce JN, Post KD. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission. Pituitary. 2007; 10(3): 275-82. PMID: 17594522. (Core: HM and MGMB)

35.       Florescu D, Kotler DP. Insulin resistance, glucose intolerance, and diabetes mellitus in HIV-infected patients.  Antiviral Therapy 2007;12:149-62. PMID: 17503657. (HM)

36. Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner S, Hanson R, Hill JO, Hubbard V, Stamm E, Pi-Sunyer FX; Diabetes Prevention Program Research Group. Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes. 2007 Jun; 56(6):1680-5. Epub 2007 Mar 15. (Core: HM)

37. Giménez-Palop O, Giménez-Pérez G, Mauricio D, González-Clemente JM, Potau N, Berlanga E, Trallero R, Laferrère B, Caixàs A.A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clin Endocrinol (Oxf). 2007 Feb;66(2):198-204. (Core: HM)

38. Grunfeld G, Thompson M, Brown SJ, Richmond G, Lee DA, Muurahainen N, Kotler DP, and the Study 24380 Investigators Group. Recombinant human growth hormone (r-hGH) to treat HIV-associated Adipose Redistribution Syndrome (HARS):  12-Week Induction and 24-Week Maintenance Therapy.  J Acquir Immun Defic Syndr 2007;45:286-97 PMID: 17592343. (Core: HM)

39. Johnson JA, Trasino SE, Ferrante AW, Jr., Vasselli JR. Prolonged Decrease of Adipocyte Size after Rosiglitazone Treatment in High- and Low-Fat-Fed Rats. Obesity (Silver Spring). 2007; 15:2653-2663. (Core: AT, MGMB and HM)

40. Kim JJ, Kido Y, Scherer PE, White MF, and Accili D. Analysis of compensatory beta cell response in mice with combined mutations of Insulin Receptor and Irs2. Am J Physiol Endocrinol Metab. 2007. 292(6): E1694-1701. PMID: 17299086. (Core: HM and MGMB)

41. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE. Obesity-associated improvements in metabolic profile through expansion of adipose tissue.  J Clin Invest. 2007 Sep;117(9):2621-37. PMCID: PMC1950456. (Core: HM)

42. Kitamura T, Kitamura YI, Funahashi Y, Shawber CJ, Castrillon DH, Kollipara R, DePinho RA, Kitajewski J, Accili D. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest. 2007;117(9):2477-85. PMCID: 1950461. (Core: AT, MGMB and HM)

43. Laferrère B, Wang K, Khan Y, McGinty J, Teixeira J, Hart AB, Heshka S,  Olivan B, Incretin levels and effect are markedly enhanced one month  after Roux-en-Y gastric bypass surgery in obese patients with type 2  diabetes. Diabetes Care 30:1709-1716, 2007. PMCID: PMC2743330. (Core: BS, BC, CL, and HM)

44. Lam TK, Gutierrez-Juarez R, Pocai A, Bhanot S, Tso P, Schwartz GJ, Rossetti L. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med. 2007 Feb;13(2):171-80..PMID: 17273170 (Core: AEP and HM)

45. Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, and Accili D. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic knockout mice. Diabetes 2007. 56:1969-1976. PMID: 17475934. (Core: HM, MGMB, and AT)

46. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 2007;6(3):208-16. (Core: AT, MBMG and HM)

47. Muntzel, M., Crespo, R., Joseph, T., Onwumere, O. Dietary salt loading exacerbates the increase in sympathetic nerve activity caused by intravenous insulin. Metabolism 2007; 56(3): 373-379. (Core: HM)

48. Naimi M, Gautier N, Chaussade C, Valverde AM, Accili D, and Van Obberghen E. Nuclear Foxo1 controls and integrates key signaling pathways in hepatocytes. Endocrinology 2007. 148:2424-2434. PMID: 17303659. (Core: HM)

49. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Eagle AR, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007; 447:1116-1120. PMCID:PMC2587297 (Core: AT, MBMG and HM)

50. Pi-Sunyer FX, Schweizer A, Mills D, Dejager S. Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes. Diabetes Res Clin Pract. 2007 Apr; 76(1):132-8. Epub 2007 Jan 12. (Core: HM)

51. Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, Dejager S. Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy. Diabetes Care. 2007 Dec; 30(12):3017-22. Epub 2007 Sep 18. (Core: HM)

52. Ranalletta, M., Du XQ, Seki Y, Glenn AS, Kruse M, Fiallo A, Estrada I, Tsao TS, Stenbit AE, Katz EB and Charron MJ.  Hepatic response to restoration of GLUT4 in skeletal muscle of GLUT4 null mice.  Am. J. Phys. 2007; 293(5):E1178-1187. (Core: HM)

53. Rosenbaum M, Nonas C, Weil M, Horlick I, Fennoy I, Vargas P. School-based intervention acutely improves insulin sensitivity and decreases inflammatory markers in early adolescence. J.Clin.Endocrinol Metab 2007;92:504-8. (Core: HM and BC).

54. Rubin CT, Capilla E, Luu YK, Busa B, Crawford H, Nolan DJ. Mittal V, Rosen C, Pessin JE, Judex S. Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low magnitude mechanical signals, an attribute achieved by suppressing mesenchymal stem cell commitment to adipocytes. Proc. Natl. Acad. Sci. USA. 2007; 104:17879-17884. PMCID: PMC2077057. (Core: HM)

55. Scribner KB, Pawlak DB, Ludwig DS. Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate.  Obesity 2007,15:2190-2199. (Core: HM)

56. Shawber, CJ, Funahashi, Y, Francisco, E, Vorontchikhina, M, Kitamura, Y, Stowell, SA, Borisenko, V, Feirt, N, Podgrabinska, S, Shiraishi,K,  Chawengsaksophak, K., Rossant, J , Accili, D, Skobe, M, and Kitajewski, J. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin. Invest. 2007.117: 3369-3382. PMID: 17948123. (Core: HM and MBMG)

57. Shen W, Punyanitya M, Chen J, Gallagher D, Albu J, Pi-Sunyer X, Lewis CE, Grunfeld C, Heshka S, Heymsfield SB. Visceral Adipose Tissue: Relationships between Single Slice Areas at Different Locations and Obesity Related Health Risks Int J Obesity Int J Obes (Lond). 2007;31(5):763-9. PMID: 17060927 (Core: BC, BS, CL and HM).

58. Sun, HD, Malabunga, M, Tonra, JR, DiRenzo, R, Carrick, FE, Zheng, H, Berthoud, HR, McGuinness, OP, Shen, J, Bohlen, P, Leibel, RL, Kussie, P. Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys. Am J Physiol Endocrinol Metab. 2007; 292:E964-76. (Core: HM and MBMG)

59. Thys-Jacobs S, McMahon D, Bilezikian J. Cyclical Changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin Endocrinol Metab 2007;92:2952-9. (Core: HM)

60.        Wang Z, Heshka S, Wang J, Gallagher D, Deurenberg P, Chen Z, Heymsfield SB. Metabolically active portion of fat-free mass: a cellular body composition level modeling analysis. Am J Physiol Endocrinol Metab. 2007 Jan; 292(1):E49-53. Epub 2006 Aug 1. PMCID: PMC2723740 (Core: BC, BS)

61. Yang Xj, Mastaitis J, Mizuno T, Mobbs CV. Glucokinase regulates reproductive function, glucocorticoid secretion, food intake, and hypothalamic gene expression. Endocrinology. 2007; 148(4): 1928-32. PMID: 17218412. (Core: HM)

62. Yim JE, Heshka S, Albu J, Heymsfield S, Kuznia P, Harris T, Gallagher D. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond). 2007;31(9):1400-5. PMCID: PMC2752367 (Core: BC, BS, CL and HM))

(Jan 2008 – Dec, 2008)

63. Ali MF,  Berk ES, Shen W, Sirak T, Yasar M, Mao XL, Shungu D, Albu JB. Body composition correlates of intramyocellular lipids (IMCL) content in healthy, pre-menopausal, non-diabetic, sedentary women.  Diabetes. 2008: 57 (S1): A717-A718). (Core: HM)

64. Anuurad E, Thomas-Geevarghese A, Devaraj S, Albu J, Minolfo R, El-Sadr WM, Lu G, Karmally W, Berglund L. Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy. Atherosclerosis. 2008 May; 198(1):192-7. Epub 2007 Nov 9. PMCID: PMC2362066. (Core: HM)

65. Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez R, Rossetti L, Gu W, Accili D. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 2008; 8:333-341. (Core: AT, MBMG and HM)

66. Berk E, Johnson JA, Lee MJ, Zhang K, Boozer CN, Pi-Sunyer FX, Fried SK, Albu JB . Higher post-absorptive skeletal muscle LPL-activity in African-American vs. Caucasian pre- menopausal women. Obesity, 16(1):199-201, 2008; (Core: BC HM, AT and BS)

67. Biddinger, S, Hernandez-Ono, T. Rask-Madsen, C. Alemán, J. Haas, J. Scapa, E., Agarwal, C. Carey, M., Stephanopoulos, G., Cohen, D., King, G., Ginsberg, H.N., Kahn, CR.  Hepatic Insulin Resistance is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis. Cell Metabolism 7:125-34, 2008. (Core: HM)

68. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX; Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008 May;87(5):1212-8. PMCID: PMC2517222 (Core: HM)

69. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Harvey-White J, Schwartz GJ, Kunos G, Rossetti L,  Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms.  Nat Med. 2008 Jun;14(6):667-75.  PMCID: PMC2671848 (Core: AEP and HM)

70. Chambers EC, Heshka S, Huffaker LY, Xiong Y, Wang J, Eden E, Gallagher D, Pi-Sunyer FX. Truncal adiposity and lung function in older black women. Lung. 2008;186(1):13-7. PMID: 17952506 (Core: BC, BS and HM)

71. Chen Y, Akirav EM, Chen W, Henegariu O, Moser B, Desai D, Shen JM, Webster JC, Andrews RC, Mjalli AM, Rothlein R, Schmidt AM, Clynes R, Herold KC. RAGE ligation affects T cell activation and controls T cell differentiation. Immunol. 2008 Sep 15;181(6):4272-8. PMC2643976. (Core: HM)

72. Cheng H, Isoda F, Belsham DD, Mobbs CV. Inhibition of agouti-related peptide expression by glucose in a clonal hypothalamic neuronal cell line is mediated by glycolysis, not oxidative phosphorylation. Endocrinology. 2008; 149(2): 703-10. PMID: 17974626. (Core: HM)

73. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K. Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons. Science. 2008 Jul 31. 29;321 (5893):1218-1221, 2008. PMID: 18669821. (Core: HM and MBMG)

74. Dokmanovic-Chouinard M, Chung WK, Chevre JC, Watson E, Yonan J, Wiegand B, Bromberg Y, Wakae N, Wright CV, Overton J, Ghosh S, Sathe GM, Ammala CE, Brown KK, Ito R, LeDuc C, Solomon K, Fischer SG, Leibel RL. Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet. 2008;4(7):e1000137. PMCID: 2464733. (Core: AT, MBMG and HM)

75. Drover VA, Nguyen DV, Bastie CC, Darlington YF, Abumrad NA, Pessin JE, London E, Sahoo D, Phillips MC.  CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice.  J. Biol. Chem. 2008; 283:13108-13115. PMCID: PMC2442355. (Core: HM)

76. Dubois SG, Tchoukalova YD, Heilbronn LK, Albu JB, Kelley DE, Smith SR, Fang X, Ravussin E; Look AHEAD Adipose Research Group. Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus. Biochem Biophys Res Commun. 2008 Mar 21;367(4):725-8. Epub 2008 Jan 7. (Core: HM)

77. Falutz J, Allas S, Mamputu J-C, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S.  Long-term Safety and Effects of Tesamorelin, a Growth Hormone- Releasing Factor Analogue, in HIV Patients with Abdominal Fat Accumulation. AIDS. 2008; 22:1719-28. PMID: 18690162. (Core: HM)

78. Freda PU, Shen W, Heymsfield SB, Reyes-Vidal CM, Geer EB, Bruce JN, Gallagher D. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab. 2008;93(6):2334-43. PMCID: PMC2435633 (Core: BC and HM)

79. Galgani JE, Heilbronn LK, Azuma K, Kelley DE, Albu JB, Pi-Sunyer FX, Smith SR, Ravussin E; Look AHEAD Adipose Research Group. Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate. Diabetes 2008. 57: 841-845. PMCID: 2756651. (Core: HM)

80. Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, BN Reid, Blaner WS, Huang L-S. Decreased lipoprotein clearance is responsible for increased cholesterol in streptozotocin treated LDL receptor knockout mice, Diabetes, 57:1674-82, 2008. PMID: 18346984. (Core: HM)

81. Grunfeld C, Kotler DP, Arnett DK, Falutz JM, Haffner SM, Hruz P, Masur H, Meigs JB, Mulligan K, Reiss P, Samaris K. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation. 2008;118:e20-8. Epub June 19 PMID: 18566314. (Core: HM)

82. He Q, Engelson ES, Ionescu G, Glesby MJ, Albu JB, Kotler DP. Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men. Antivir Ther. 2008;13(3):423-8. PMCID: PMC2871284. (Core: BC, BS, AND HM)

83. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M, Ferrante AW, Jr., Mynatt RL, Burris TP, Dong JZ, Halem HA, Culler MD, Heisler LK, Stephens JM, Butler AA. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008; 8:468-481. PMCID:PMC2746325 (Core: AT, HM and MBMG)

84. Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, Yapp K, Olivan B. Gastric bypass  surgery versus low calorie diet: Effect of weight loss on glucose and  incretin levels in patients with type 2 diabetes. J Clin Endo Metab  2008 Jul;93(7):2479-85. PMCID: PMC 2453054. (Core: BS, CL and HM)

85. Longuet, C., Sinclair EM, Maida A, Maziarz LL, Charron MJ and Drucker DJ.  The glucagon receptor is required for the adaptive metabolic response to fasting.  Cell Metabolism 2008; 8:359-371. PMCID: PMC2593715. (Core: HM)

86. Madden E, Lee G, Kotler DP, Wanke C, Lewis CE, Tracy R, Heymsfield S, Shlipak MG, Bacchetti P, Scherzer R; Grunfeld C.  Association of antiretroviral therapy with fibrinogen levels in HIV-infection. AIDS. 2008;22:707-15. PMID: 18356600. (Core: HM)

87. Morrow J., Gluck M., Lorence M., Flanbaum L., Geliebter A. Night eating status and  influence on body weight, body image, hunger, and cortisol pre- and post- Roux-en-Y Gastric Bypass (RYGB) surgery. Eat Weight Disord. 2008 Dec; 13(4) 96-9. (Core: HM and CL)

88. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008; 7:496-507. PMCID:PMC2587370 (Core: AT, AP, MGMB and HM)

89. Ota, T., Gayet, C., Ginsberg, H.N. Inhibition of apolipoprotein B100 secretion by lipid-induced endoplasmic reticulum stress.  J Clin. Invest. 118:316-32, 2008 PMCID: PMC2104481. (Core: HM)

90. Park T-S, Hu Y, Noh H-L, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang H-C, Abel ED, Goldberg IJ. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.  J Lipid Res, 49:2101-12, 2008. PMCID: PMC2533410. (Core: HM)

91. Petrescu O, Cheema AF, Fan X, Bradbury MW, Berk PD. Differences in adipocyte long chain fatty acid uptake in Osborne-Mendel and S5B/Pl rats in response to high-fat diets. Int J Obes (Lond). 2008 May;32(5):853-62. (Core: HM and AP)

92. Pratley RE, Schweizer A, Rosenstock J, Foley JE, Banerji MA, Pi-Sunyer FX, Mills D, Dejager S. Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database. Diabetes Obes Metab. 2008 Sep; 10(10):931-8. (Core: HM)

93. Raffo, A, Hancock K, Polito T, Xie Y, Andan G, WItkowski P, Hardy M, Barba P, Ferrara C, Maffei A, Freeby M, Goland R, Leibel RL, Sweet IR, Harris PE. Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J Endocrinol. 2008 Jul;198(1):41-9. PMCID: PMC2712213. (Core: HM and MGMB)

94. Ramasamy R, Yan SF, Herold K, Clynes R, Schmidt AM. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis. Ann N Y Acad Sci. 2008 Apr;1126:7-13.PMID: 18448789. (Core: HM)

95. Reid BN, Ables GP, Otlivanchik OA, Schoiswohl G, Zechner R, Blaner WSGoldberg IJ, Schwabe RF, Chua SC Jr., Huang L-S. Hepatic Overexpression of Hormone-sensitive Lipase and Adipose Triglyceride Lipase Promotes Fatty Acid Oxidation, Stimulates Direct Release of Free Fatty Acids and Ameliorates Steatosis. J Biol Chem, 57:1674-82, 2008. PMCID: PMC2442319. (Core: HM and MGMB)

96. Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008 Oct;88(4):906-12. (Core: HM and MGMB)

97. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest. 2008 Jul;118(7):2583-91. PMCID: PMC2430499. (Core: HM and MGMB)

98. Ruilope LM, Despres JP, Scheen A, Pi-Sunyer X, Mancia G, Zanchetti A, Van Gaal L; Effect of Rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results. J Hypertension 26: 357-367, 2008. PMID: 18192851. (Core: HM)

99. Scherzer R, Shen W, Bacchetti P, Kotler D, Lewis CE, Shlipak MG, Heymsfield SB, Grunfeld C; Study of Fat Redistribution Metabolic Change in HIV Infection (FRAM) Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. Am J Clin Nutr. 2008 Jun;87(6):1809-17. PMCID: PMC2587301. (Core: HM and CL)

100.       Takahashi M, Yokoyama M, Hiyama Y, Hu Y, Melford K, Bensadoun A, Goldberg IJ. In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation. ATVB 28:455-462, 2008. PMID: 18258818.  (Core: HM)

101.       Tien PC, Kotler DP, Overton ET, Lewis C, Rimland D, Bacchetti P, Scherzer R, Gripshover B, and Fram.  Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals.  J Acquir Immunedefic Syndr. 2008; 48:169-76. PMCID: PMC2776053. (Core: HM)

102.       Thys-Jacobs S, McMahon D, Bilezikian J. Differences in free estradiol and sex hormone binding globulin in women with and without premenstrual dysphoric disorder. J Clin Endocrinol Metab 2008;93 96-102. PMCID: PMC2190737. (Core: HM)

103.       Thys-Jacobs S, McMahon D, Bilezikian J. Lower insulin-like growth factor-1 concentrations in women with premenstrual disorder. Am J Obstet Gynecol 2008; 198:506. (Core: HM)

104.       van de Wall E, Leshan R, Xu AW, Balthasar N, Coppari R, Liu SM, Jo YH, MacKenzie RG, Allison DB, Dun NJ, Elmquist J, Lowell BB, Barsh GS, de Luca C, Myers MG Jr, Schwartz GJ, Chua SC Jr. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion.  Endocrinology. 2008 Apr;149(4):1773-85.  PMCID: PMC2276717  (Core: AEP, MB/MG and HM)

105.       Van Gaal L, Pi-Sunyer X, Despres JP, McCarthy C, Scheen A; Efficacy and safety of Rimonabant for improvement of multiple cardiometabolic risk factor in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care 2008. 31: S229-S240. PMID: 18227491. (Core: HM and CL)

106.       Wang PY, Caspi L, Lam CK, Chari M, Li X, Light PE, Gutierrez-Juarez R, Ang M, Schwartz GJ, Lam TK. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production.  Nature. 2008 Apr 24;452(7190):1012-6.  PMID: 18401341 (Core: AEP and HM)

107.      Wardle J, Carnell S, Haworth CMA, Farooqi IS, O’Rahilly S & Plomin, R. Obesity-associated variation in FTO is associated with diminished satiety in children. Journal of Clinical Endocrinology & Metabolism 2008; 93, 3640-3643. (MG CORE)

108.       Wu, E.X., Tang, H., Tong, C., Heymsfield, S.B. and Vasselli, J.R. In vivo MRI quantification of individual muscle and organ volumes for assessment of anabolic steroid growth effects. Steroids 2008. 73: 430-440. (Core: HM)

109.       Yim JE, Heshka S, Albu JB, Heymsfield SB, Gallagher D. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J Appl Physiol. 2008;104(3):700-7. PMCID: PMC2745606 (Core: BC, BS, CL and HM)

110.       Zizola CF, Schwartz GJ, Vogel S. Cellular retinol-binding protein type III is a PPARgamma target gene and plays a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1358-68.7. PMCID: PMC2603557 (Core: AEP and HM)

(Jan 2009 – Dec, 2009)

111.       Berglund, E.D., Lee-Young RS, Lustig DG, Lynes SG, Donahue EP, Camacho RC, Meredith ME, Magnuson MA, Charron MJ and Wasserman DH. Hepatic energy state is regulated by glucagon receptor signaling in mice.  J. Clin. Invest. 2009; 119:2412-2422. PMCID: PMC2719934. (Core: HM)

112.       Brownley, K.A., Heymen, S., Hinderliter, A.L., & MacIntosh, B. Effect of glycemic load on peptide-YY levels in a biracial sample of obese and normal weight women. Obesity, [Oct. 29, 2009 Epub ahead of print]. PMID: 19875990. (Core: HM)

113.       Cheng H, Isoda F, Mobbs CV. Estradiol impairs hypothalamic molecular responses to hypoglycemia. Brain Res. 2009; 1280: 77-83. PMCID: PMC2755295. (Core: HM)

114.       Davis NJ, Tomuta N, Schechter C, Segal-Isaacson CJ, Stein D, Zonszein J,Wylie-Rosett J.  Comparative Study of a One Year Dietary Intervention of a Low-Carbohydrate to a Low-Fat Diet on Weight and Glycemic Control in Type 2 Diabetes.  Diabetes Care. 2009 Apr 14. PMCID: PMC2699720. (Core: HM)

115.       Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, Wadden TA, Kelley D, Wing RR, Pi-Sunyer FX, Reboussin D, Kuna ST; Sleep AHEAD Research Group of Look AHEAD Research Group.A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009. 169: 1619-1626. PMCID: PMC2879275. (Core: HM)

116.      Gallagher D, Kelley DE, Yim JE, Spence N, Albu J, Boxt L, Pi-Sunyer FX, Heshka S. MRI Ancillary Study Group of the Look AHEAD Research Group. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr. 2009 Mar;89(3):807-14. PMCID: PMC2714397. (Core: BC, BS and HM)

117.       Gelling, R.W., Du XQ, Cui L, Romer J, Pederson RA, Vuguin PM, Leiser M, Sorensen H, Holst JJ, Fedelius C, Hohnsen PB, Fleischer N, McIntosh CHS, Nishimura E and Charron MJ.  Pancreatic β-cell overexpression of the glucagon receptor gene results in enhanced β-cell function and mass.  Am. J. Physiol. (Endo Metab) 2009; 297(3):E695-707. (Core: HM)

118.       German J, Kim F, Schwartz GJ, Havel PJ, Rhodes CJ, Schwartz MW, Morton GJ.  Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve.  Endocrinology. 2009 Oct;150(10):4502-11. PMID: 19574396 (Core: AEP and HM)

119.       Greenberg JA., Owen DR., Geliebter A. Decaffeinated coffee and glucose metabolism in   young men. Diabetes Care. 2010 Feb;33(2):278-80.2009. PMCID: PMC2809264. (Core: HM)

120.       Hartil, K., Vuguin PM, Kruse M, Schmuel E, Fiallo A, Vargas C, Warner MJ, Durand JL, Jelicks LA and Charron MJ.  Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in uteroPeds. Res. 2009; 66:368-373. PMCID: PMC2795789. (Core: HM)

121.       He Q, Heshka S, Albu J, Boxt L, Krasnow N, Elia M, Gallagher D. Smaller organ mass with greater age, except for heart. J Appl Physiol. 2009;106(6):1780-4. PMCID: PMC2692775. (Core: BC, CL, BS and HM)

122.       Hou JC, Williams D, Vicogne J, Pessin JE.  The GLUT2 glucose transporter undergoes plasma membrane endocytosis and lysosomal degradation in a glucose-dependent manner. Endocrinology. 2009; 150:4056-4064. PMCID: PMC2736072. (Core: HM)

123.       Lin HV, Plum L, Ono H, Gutiérrez-Juárez R, Shanabrough M, Borok E, Horvath TL, Rossetti L, and Accili DDivergent Regulation of Energy Expenditure and Hepatic Glucose Production by Insulin Receptor in AgRP and POMC Neurons. Diabetes in press. 2009. PMCID: PMC2809966. (Core: HM)

124.       Laferrère B. Effect of gastric bypass surgery on the incretins.  Diabetes and Metabolism 35 (2) 513-517, 2009. PMCID: PMC2842993. (Core: BS, CL and HM)

125.       Lin HV, Plum L, Ono H, Gutiérrez-Juárez R, Shanabrough M, Borok E, Horvath TL, Rossetti L, and Accili DDivergent Regulation of Energy Expenditure and Hepatic Glucose Production by Insulin Receptor in AgRP and POMC Neurons. Diabetes in press. 2009. PMCID: PMC2809966. (Core: HM)

126.       Lu G, Thomas-Geevarghese A, Anuurad E, Raghavan S, Minolfo R, Ormsby B, Karmally W, El-Sadr WM, Albu J, Berglund L. Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy. Metab Syndr Relat Disord. 2009. Jun;7(3):199-204. (Core: HM)

127.       Luu YK, Lublinsky S, Ozcivici E, Capilla E, Pessin JE, Rubin CT, Judex S. In vivo quantification of subcutaneous and visceral adiposity by micro-computed Tomography in a small animal model. Med. Eng. Phys. 2009; 31:34-41. PMCID: PMC2659633. (Core: HM)

128.       Madsen AN, Jelsing J, van de Wall EH, Vrang N, Larsen PJ, Schwartz GJ. Rimonabant induced anorexia in rodents is not mediated by vagal or sympathetic gut afferents.  Neurosci Lett. 2009 Jan 2;449(1):20-3. (Core: AEP and HM)

129.       Oliván B, Teixeira J, Bose M, Bawa B, Chang T, Summe H, Lee H,  Laferrère B.  Effect of weight loss by diet or gastric bypass surgery on PYY3-36 levels. Ann Surg. 2009 Jun;249(6):948-53. PMCID: PMC2845170. (Core: BS, CL and HM)

130.       Ortega Martinez de Victoria E, Xu X, Koska J, Francisco AM, Scalise M, Ferrante AW, Jr., Krakoff J. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes. 2009; 58:385-393. PMCID:PMC2628612 (Core: AT, MBMG and HM)

131.       Pasarica M, Tchoukalova YD, Heilbronn LK, Fang X, Albu JB, Kelley DE, Smith SR, Ravussin E; ; The Look AHEAD Adipose Research Group. Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring). 2009 Jul 23.  PMID: 19629054. (Core: BC, HM, and CL)

132.       Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS, Matsumoto M, Kim AJ, Cawley NX, Paik JH, Loh YP, DePinho RA, Wardlaw SL, Accili D. The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat Med. 2009;15(10):1195-201. PMCID: 2777744. (Core: AT, MBMG, and HM)

133.       Reyes-Soffer G, Chen N-T, Torres, M., Ngai, C., Holleran S., Ramakrishnan, R., Blaner W.S., Berglund, L., Ginsberg, H.N., Tuck, C.  Measures of Postprandial Lipoproteins Are Not Associated with Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.  J Lipid Res  50:1901-1909, 2009.  PMC2724776 (Core: HM)

134.      Snitker S, Fujishima Y, Shen H, Ott S, Pi-Sunyer X, Furuhata Y, Sato H, Takahashi M. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications.  Am J Clin Nutr 2009. 89: 45-50. (Core: HM)

135.       Stratigopoulos G, LeDuc CA, Matsuoka N, Gutman R, Rausch R, Robertson SA, Myers MG, Jr., Chung WK, Chua SC, Jr., Leibel RL. Functional consequences of the human leptin receptor (LEPR) Q223R transversion. Obesity (Silver Spring). 2009;17(1):126-35. PMCID: 2808713. (Core: AT, MBMG, and HM)

136.   Vasselli JR, Currie PJ, Pi-Sunyer FX. Glycemic Basis for Reduced Feeding by Intact and Diabetic Rats in Response to Injections of Insulin Detemir.Diabetologia 2009. 52(S1): A501, p. 201. (Core: HM)

(Jan 2010 – May, 2010)

137.       Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E; Look AHEAD Adipose Research Group. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes. 2010 Mar; 59(3):627-33. Epub 2009 Dec 22. PMCID: PMC2828653 (Core: BC, HM, and CL)

138.       Albu JB, Lu J, Mooradian AD, Krone RJ, Nesto RW, Porter MH, Rana JS, Rogers WJ, Sobel BE, Gottlieb SH; BARI 2D Study Group. Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Obesity (Silver Spring). 2010 May;18(5):1046-54. Epub 2009 Oct 29. (Core: HM)

139.       Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group. Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010 Jan;33(1):197-9.  PMCID: PMC2797972. (Core: HM)

140.       Bose M, Machineni S, Oliván B, Teixeira J, McGinty JJ, Bawa B, Koshy N, Colarusso A, Laferrère B. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring). 2010 Jun;18(6):1085-91. PMCID: PMC2877144. (Core: HM and CL)

141.       Bose M, Teixeira J, Olivan B, Scherer, PE, Pi-Sunyer, FX, Bawa  B, Laferrère B. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. Journal of Diabetes, 2, 2010, 47-55. (Core: HM and CL)

142.       Goldsmith R, Joanisse DR, Gallagher D, Pavlovich K, Shamoon E, Leibel RL, Rosenbaum M. Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. Am J Physiol Regul Integr Comp Physiol. 2010;298(1):R79-88. PMCID: 2806213. (Core: AT, BC, MGMB, and HM)

143.       Laferrère B, Swerdlow N, Bose M, Oliván B, Bawa B, Teixeira J, McGinty  J, Arias S, Rother K. Rise of oxyntomodulin in response to oral  glucose after gastric bypass surgery in patients with type 2 diabetes.  J Clin Endo Metab EPub May 2010. PMID: 20501690 (Core: BS, CL, and HM)

144.       Obstfeld AE, Sugaru E, Thearle M, Francisco AM, Gayet C, Ginsberg HN, Ables EV, Ferrante AW, Jr. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes. 2010; 59:916-925. PMCID:PMC2844839 (Core: AT, MGMB and HM)

145.       Walewski JL, Ge F, Gagner M, Inabnet WB, Pomp A, Branch AD, Berk PD. Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization .Obes Surg. 2010 Jan;20(1):93-107. (Core: AP and HM)

146.       Wang Z, Heymsfield SB, Chen Z, Zhu S, Pierson RN. Estimation of percentage body fat by dual-energy x-ray absorptiometry: evaluation by in vivo human elemental composition. Phys Med Biol. 2010 May 7; 55(9):2619-35. (Core: BC and HM)

147.       Wang Z, Heymsfield SB, Ying Z, Pierson RN Jr, Gallagher D, Gidwani S. A cellular level approach to predicting resting energy expenditure: Evaluation of applicability in adolescents. Am J Hum Biol. 2010 Jan 7. PMCID: PMC2883012. (Core: BC and HM)

Review Articles

(Jan 2006 – Dec 2006)

1.   Albu J, Gottlieb SH, August P, Nesto RW, Orchard TJ. Modifications of coronary risk factors. Am J Cardiol 2006; 19;97 (12A):41G-52G. (Core: BS and HM)

2.   Berkman ND, Bulik CM, Brownley KA, Lohr K., Sedway JA, Rooks A, Gartlehner G. Management of eating disorders. Evidence report/technology assessment (Full Report). 2006; 135: 1-166. (Core: HM)

3.   Gluck ME. Stress Response and Binge Eating Disorder. Appetite 2006, Jan;46(1):26-30. (Core: HM)

4.   Lee H, Te C, Koshy S, Teixeira JA, Pi-Sunyer FX, Laferrère B. Does ghrelin really matter after bariatric surgery? Surg Obes Relat Dis. 2006 Sep-Oct;2(5):538-48. (Core: HM)

5.   Pi-Sunyer FX. Use of lifestyle changes treatment plans and drug therapy in controlling cardiovascular and metabolic risk factors. Obesity (Silver Spring) 2006; 14 Suppl 3:135S-142S:135S-142S. (Core: HM)

(Jan 2007 – Dec 2007)

6.   Belle SH, Berk PD, Courcoulas AP, Flum DR, Miles CW, Mitchell JE, Pories WJ, Wolfe BM, Yanovski SZ; Longitudinal Assessment of Bariatric Surgery Consortium Writing Group. Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. SurgObesRelat Dis. 2007 Mar-Apr;3(2):116-26. Review. (Core: HM)

7.   Bulik, C.M., Brownley, K.A., & Shapiro, J. R. Diagnosis and management of binge eating disorder. World Psychiatry 2007; 6, 142-148. PMID: 18188431. (Core: HM)

8.   Burguera B, Agusti A, Arner P, Baltasar A, Barbe F, Barcelo A, Breton I, Cabanes T, Casanueva FF, Couce ME, Dieguez C, Fiol M, Fernandez Real JM, Formiguera X, Fruhbeck G, Garcia Romero M, Garcia Sanz M, Ghigo E, Gomis R, Higa K, Ibarra O, Lacy A, Larrad A, Masmiquel L, Moizé V, Moreno B, Moreiro J, Ricart W, Riesco M, Salinas R, Salvador J, Pi-Sunyer FX, Scopinaro N, Sjostrom L, Pagan A, Pereg V, Sánchez Pernaute A, Torres A, Urgeles JR, Vidal-Puig A, Vidal J, Vila M. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients. J Endocrinol Invest. 2007 Nov; 30(10):844-52. (Core: HM)

9.   Clynes R, Herold K, Schmidt AM. RAGE: exacting a toll on the host in response to polymicrobial sepsis and Listeria monocytogenes. Crit Care. 2007;11(6):183. Review. PMC2246224. (Core: HM)

10. Clynes R, Moser B, Yan SF, Ramasamy R, Herold K, Schmidt AM. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med. 2007 Dec;7(8):743-51. Review. PMID: 18331232. (Core: HM)

11. Haworth CMA, Plomin R, Carnell S & Wardle J. Childhood Obesity: Genetic and Environmental Overlap with Normal-Range BMI, Obesity 2007, 16, 1586-90. (Core: HM)

12. Herold K, Moser B, Chen Y, Zeng S, Yan SF, Ramasamy R, Emond J, Clynes R, Schmidt AM. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol. 2007 Aug;82(2):204-12. Epub 2007 May 18. Review.PMID: 17513693. (Core: HM)

13. Pi-Sunyer X. The relation of adipose tissue to cardiometabolic risk. Clinical Cornerstone 2007;8:S14-S23. (Core: HM)

(Jan 2008 – Dec 2008)

14. BerkPD. Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome. Hepatology. 2008 Nov;48(5):1362-76. Review. (Core: HM)\

15. Berk ES, Shen W, Ali MF, Sirak T, Yasar M, Mao XL, Shungu D, Albu JB. Ethnic differences in intramyocellular lipids (IMCL): Lessons from dietary intervention studies. Diabetes. 2008: 57 (S1): A719-A719). (Core: HM)

16. Bloom SR, Kuhajda FP, Laher I, Pi-Sunyer X, Ronnett GV, Tan TMM, Weigle DS. The obesity epidemic: pharmacological challenges.  Mol Interv 2008. 8: 82-98. PMID: 18403653. (Core: HM)

17. Chung, WK  and Leibel, RL.  Considerations regarding the genetics of obesity. Obesity. 2008:16 3:S33-9  PMCID: PMC2682366. (Core: HM and MGMB)

18. Geliebter A, Hashim SA, Gluck ME. Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED).Physiol Behav. 2008 Aug 6;94(5):696-9. (Core: IB and HM)

19. Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr. Rev. 2008. 29:62-75. PMCID: PMC2244935. (Core: HM)

20. Kotler DP. HIV and Antiviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-infected Patients. J Acquir Immune Defic Syndr 2008;49:Suppl 2:S79-85. PMID: 18725816. (Core: HM)

21. Pi-Sunyer X. Glycemic index in early type 2 diabetes. Am J Clin Nutr 2008;87:3-4. (Core: BS and HM)

22. Twaddell WS, Lefkowitch J, Berk PD. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.Semin Liver Dis. 2008;28(1):128-34. (Core: HM)

23. Verna EC, Berk PD. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis. 2008 Nov;28(4):407-26. Review. (Core: HM)

(Jan 2009 -  Dec 2009)

24. Anthony L, Freda PU. From somatostatic to octrotide LAR: evolution of a somatostatin analogue. Curr Med Res Opin. 2009 Dec; 25(12): 2989-99. PMID: 19842996 (Core: HM)

25. Bays HE, Laferrère B, Dixon J, Aronne L, Gonzalez-Campoy JM, Apovian C, Wolfe BM. Consensus. Adiposopathy and bariatric surgery working group. Int J Clin Pract 2009. 63, 9, 1285-1300. PMCID: PMC2779983. (Core: HM)

26. Bose M, Oliván B, Teixeira J, Pi-Sunyer FX, Laferrère B.  Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg 2009. 19 (2) 217-229 PMCID: PMC2854668. (Core: HM)

27. Bose M, Oliván B, Laferrère B. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Review. Curr Opin Endocrinol Diabetes Obes. 2009 16(5):340-6. PMID: 19584720. (Core: HM)

28. Freda PU. Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol (Oxf). 2009 Aug; 71(2): 166-70. PMID: 19226264. (Core: HM)

29. Kotler DP. Hepatitis C, human immunodeficiency virus and metabolic syndrome: interactions. Liver International 2009;29(s2):38-46. (Core: BC and HM)

30. Stunkard AJ, Allison KC, Geliebter A, Lundgren JD, Gluck ME, O’Reardon, JP. Development of Criteria for a Diagnosis: Lessons from the Night Eating Syndrome. Compr Psychiatry. 2009 Sep-Oct;50(5):391-9. (Core: HM)

(Jan 2010 -  May 2010)

31. Allison KC, Lundgren JD, O’Reardon, JP, Geliebter A, Gluck ME, Vinai P, Mitchell JE, Schenck CH, Howell MJ, Crow SJ, Engel S, Latzer Y, Tzischinsky O, Mahowald MW, Stunkard AJ. Proposed Diagnostic Criteria for Night Eating Syndrome. Int J Eat Disord. 2010 Apr;43(3):241-7. NIHMS145358. (Core: HM)

32. Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res. 2010 Feb; 20(1): 19-25. PMID: 19818659. (Core: HM)

33. Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays—a 2009 update. Growth Horm IGF Res. 2010 Feb; 20(1): 8-18. PMID: 19818658. (Core: HM)

34. Ochner C, Gibson C, Carnell S, Dambkowski C & Geliebter A (2010) Alterations in the neurohormonal regulation of energy intake following bariatric surgery for obesity. Physiology & Behavior 2010. (Core: HM)

35. Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf). 2010 Feb; 7(2): 203-8. PMID: 19473180. (Core: HM)

Book Chapters

(Jan 2006 – Dec 2006)

1.        Pi-Sunyer X. Foreword to The Diabetes in Pregnancy Dilemma. Oded Langer, ED. 2006. (Core: HM)

(Jan 2008 – Dec 2008)

2.        Bowers C.Y., Hurley D.L., Laferrère B and Veldhuis J.D. The Role of GHSs/Ghrelin in Feeding and Body Composition in Obesity and Energy Metabolism: Research and Clinical Applications. Ed: Patricia A. Donohue. 2008. (Core: HM)

(Jan 2010 – May 2010)

3.        Gandikota P and Laferrère B. The role of bariatric surgery in obese patients with diabetes. Primary or rescue therapy? in Controversies in Diabetes Management.  Wiley-Blackwell Ed: Adrian Vella & Robert A. Rizza (in print June 2010). (Core: HM)

4.        Puma L, Ochner CN, Geliebter A. The Psychology of Obesity. In Tsichlia
G, Johnstone A, Qvortru M, ed. Matters of Fat. Aberdeen, UK: M&K, in
press. (Core: HM)

Copyright 2010, New York Obesity Nutrition Research Center. 
All Rights Reserved.